Also listed on Clarus Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 6, 2027 · High confidence
20-year base term ended Apr 14, 2026
Held by Tolmar, Inc.
Filed Oct 17, 2019 as application 16/656,178 · Granted May 17, 2022
Base term plus 267 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
Apr 14, 2006
Apr 14, 2006
Term ends
Jan 6, 2027
Jan 6, 2027
Granted
May 17, 2022
May 17, 2022
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
267
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,179,403, US 8,492,369, US 8,778,916, to Jan 6, 2027. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
19
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 267 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 1 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 14, 2006, when application PCT/US2006/014207, the earliest non-provisional in its chain, was filed (this one was filed Oct 17, 2019) | Apr 14, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +267 days, USPTO patent term adjustment record | Jan 6, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,179,403, US 8,492,369, US 8,778,916) | resolves to Jan 6, 2027, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 6, 2027 | High confidence |
This family
| Application PCT/US2006/014207 | PCT application no patent term | no patent term |
| US 8,241,664 | In force Mar 2029 | Mar 2029 |
| Application 13/553,586 | Abandoned not computed | not computed |
| US 8,778,917 | Term ended Apr 2026 | Apr 2026 |
| US 8,828,428 | Term ended Apr 2026 | Apr 2026 |
| Application 14/303,179 | Abandoned not computed | not computed |
| Application 14/820,765 | Abandoned not computed | not computed |
| Application 14/820,749 | Abandoned not computed | not computed |
8 of 19 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 12, 2020 Reel 52099, frame 349 | Clarus Therapeutics, Inc. | U.S. Bank National Association | Security Interest |
| Dec 14, 2020 Reel 54641, frame 925 | Dudley, Robert E.; Constantinides, Panayiotis P. | Clarus Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 15, 2022 Reel 61774, frame 516 | Clarus Therapeutics, Inc. | Tolmar, Inc. | Assignment of Assignor's Interest |
| Dec 6, 2022 Reel 62000, frame 52 | U.S. Bank Trust Company, National Association, as Successor to U.S. Bank National Association | Clarus Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2027
Term ends Jan 6, 2027. No further fees fall due before then
Note
The 267 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,179,403, US 8,492,369, US 8,778,916, ends no earlier than this term, so it caps nothing.
Citations
9
later US patents cite this one
That is top 25% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.